Autoimmune-related pancreatitis

Sarles H, Sarles JC, Camatte R, et al.: Observation on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut 1965, 6:545–559. Montefusco PP, Geiss AC, Bronzo RL, et al.: Sclerosing cholangitis, chronic pancreatitis, and SjS:A syndrome complex. Am J Surg 1984, 147:822–826. Epstein O, Chapman RWG, Lake-Bakaar G, et al.: The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology 1982, 83:1177–1182. Strand V, Talal N: Advances in the diagnosis and concept of Sjörgen’s syndrome (autoimmune exocrinopathy). Bull Rheum Dis 1979, 30:1046–1052. Toki F, Kozu T, Oi I: An unusual type of chronic pancreatitis showing diffuse irregular narrowing of the entire main pancreatic duct on ERC-A of four cases. Endoscopy 1992: 24:640. Lankisch PG, Koop H, Seelig R, et al.: Antinuclear and pancreatic acinar cell antibodies in pancreatic disease. Digestion 1981, 21:65–68. Yoshida K, Toki F, Takeuchi T, et al.: Chronic pancreatitis caused by autoimmune abnormality. Proposal of concept of autoimmune pancreatitis. Dig Dis Sci 1995, 40:1561–1568. Ohana M, Okazaki K, Hajiro K, et al.: Multiple pancreatic masses associated with autoimmunity. Am J Gastroenteeol. 1996, 93:2607–2609. Horiuchi A, Kaneki T, Yamamura M, et al.: Autoimmune chronic pancreatitis simulating pancreatic lymphoma. Am J Gastroenterol 1996, 91:2607–2609. Horiuchi A, Kawa S, Akamatsu T, et al.: Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: a case report and review of the Japanese literature. Am J Gastroenterol 1998, 93:99–102. Tanaka S, Kobayashi T, Nakanishi K, et al.: Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet 2000, 356:910–911. The effects of improvement in diabetes mellitus-associated autoimmune pancreatitis by steroid therapy is discussed. UchidaK, Okazaki K, Konishi Y, et al.: Clinical analysis of autoimmune-related pancreatitis. Am J Gastorenterol 2000, 95:2788–2794. Data from patients with autoimmune-related pancreatitis are analyzed and the effects of steroid therapy are mentioned. Coll J, Navarro S, Tomas R, et al.: Exocrine pancreatic function in Sjogren syndrome. Arch Intern Med 1989, 149:848–852. Sheikh SH, Shaw-Stiffel TA: The gastrointestinal manifestations of Sjogren’s syndrome. Am J Gastroenterol 1995, 90:9–14. Waldram R, Kopelman H, Tsantoulas D, et al.: Chronic pancreatitis, sclerosing cholangitis, and sicca complex in two siblings. Lancet 1975, 7906:550–552. Okazaki K, Uchida K, Ohana M, et al.: Autoimmunerelated pancreatitis is associated with autoantibodies and Th1/Th2-type cellular immune response. Gastroenterology. 2000, 118:1–10. Etemad B, Whitcomb DC: Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001, 120:682–707. OkazakiK, Uchida K, Chiba T: Recent concept of autoimmune-related pancreatitis. J Gastroenterol 2001, 36:293–302. Recent concepts of autoimmune-related pancreatitis are reviewed. Irie H, Honda H, Baba S, et al.: Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 1998, 170:1323–1327. Furukawa N, Muranaka T, Yasumori K, et al.: Autoimmune pancreatitis: radiologic findings in three histologically proven cases. J Comput Assist Tomogr 1998, 22:880–883. Nakamoto Y, Sakahara H, Higashi T, et al.: Autoimmune pancreatitis with F-18 fluoro-2-deoxy-D-glucose PET findings. J Clin Nucl Med 1999, 24:778–780. Hamono H, Kawa S, Horiuchi A, et al.: High serum IgG4 concentrations in patients with sclerosing cholangitis. N Engl J Med 2001, 344:732–738. 2000 Drug Topics Red Book. Montvale, NJ: Medical Economics Co.; 2000.